Thrivent Financial For Lutherans Has $373,000 Position in Halyard Health, Inc. (HYH)
Thrivent Financial For Lutherans raised its holdings in Halyard Health, Inc. (NYSE:HYH) by 7.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,497 shares of the medical instruments supplier’s stock after purchasing an additional 650 shares during the quarter. Thrivent Financial For Lutherans’ holdings in Halyard Health were worth $373,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. Riverhead Capital Management LLC raised its position in Halyard Health by 88.1% in the second quarter. Riverhead Capital Management LLC now owns 3,197 shares of the medical instruments supplier’s stock valued at $126,000 after purchasing an additional 1,497 shares during the period. LS Investment Advisors LLC raised its position in Halyard Health by 16.1% in the second quarter. LS Investment Advisors LLC now owns 4,017 shares of the medical instruments supplier’s stock valued at $158,000 after purchasing an additional 556 shares during the period. Victory Capital Management Inc. purchased a new stake in Halyard Health in the first quarter valued at $153,000. Tower Research Capital LLC TRC raised its position in Halyard Health by 102.5% in the first quarter. Tower Research Capital LLC TRC now owns 4,836 shares of the medical instruments supplier’s stock valued at $184,000 after purchasing an additional 2,448 shares during the period. Finally, Capstone Asset Management Co. raised its position in Halyard Health by 6.2% in the second quarter. Capstone Asset Management Co. now owns 5,663 shares of the medical instruments supplier’s stock valued at $222,000 after purchasing an additional 330 shares during the period. Institutional investors own 91.02% of the company’s stock.
A number of research firms have commented on HYH. Zacks Investment Research upgraded Halyard Health from a “sell” rating to a “hold” rating in a research report on Thursday. Stifel Nicolaus restated a “buy” rating and issued a $45.00 target price on shares of Halyard Health in a research report on Thursday, September 21st. BidaskClub upgraded Halyard Health from a “hold” rating to a “buy” rating in a research report on Wednesday, June 28th. Stephens upgraded Halyard Health from an “equal weight” rating to an “overweight” rating in a research report on Thursday, August 3rd. Finally, Deutsche Bank AG lifted their target price on Halyard Health from $35.00 to $42.00 and gave the company a “buy” rating in a research report on Thursday, August 3rd. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $42.25.
Shares of Halyard Health, Inc. (HYH) opened at 44.01 on Friday. Halyard Health, Inc. has a 52-week low of $31.59 and a 52-week high of $46.63. The firm has a 50-day moving average price of $45.23 and a 200-day moving average price of $40.71. The stock has a market cap of $2.06 billion, a P/E ratio of 42.32 and a beta of 1.75.
Halyard Health (NYSE:HYH) last posted its quarterly earnings data on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.14. Halyard Health had a return on equity of 8.29% and a net margin of 3.06%. The business had revenue of $399.20 million for the quarter, compared to analysts’ expectations of $399.16 million. During the same quarter last year, the firm earned $0.45 earnings per share. The business’s revenue was down .2% on a year-over-year basis. On average, analysts anticipate that Halyard Health, Inc. will post $1.95 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Thrivent Financial For Lutherans Has $373,000 Position in Halyard Health, Inc. (HYH)” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this story can be viewed at https://www.watchlistnews.com/thrivent-financial-for-lutherans-has-373000-position-in-halyard-health-inc-hyh/1645104.html.
Halyard Health Profile
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health, Inc. (NYSE:HYH).
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.